Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2029

Conditions
Sustained Monomorphic VT (MMVT)Recurrent Ventricular Tachycardia
Interventions
DEVICE

Isochronal Late Activation Mapping (ILAM)

an isochronal late activation mapping (ILAM) display with automated last deflection annotation (EnSite X™) will be used to identify regions of isochronal crowding around a line of conduction block for targeted ablation therapy using a standard irrigated tip catheter (Flexability SE \& Tactiflex catheters)

DEVICE

High Density Voltage Mapping

high-density voltage mapping will serve as the method to display the electroanatomic substrate for extensive and diffuse ablation within the low voltage area (\<1.5 mV).

Trial Locations (1)

85006

Banner University Medical Center Phoenix, Phoenix

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

University of Arizona

OTHER

NCT06931821 - Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial | Biotech Hunter | Biotech Hunter